The document discloses that GPT-5.5 was assessed for its potential to provide assistance in biological and chemical weapons-relevant domains, received a medium risk rating, and is subject to usage policy restrictions on such content as the primary mitigation mechanism.
This analysis describes what OpenAI's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
The disclosure that GPT-5.5 was evaluated and rated at medium risk in biological and chemical threat domains is operationally significant for regulatory compliance purposes, as these domains are subject to specific legal restrictions in most jurisdictions. The primary mitigation described is usage policy enforcement rather than absolute technical restriction.
Interpretive note: The document does not specify the precise content categories or request patterns that trigger usage policy enforcement in the biological and chemical risk domains, making it difficult to assess the practical scope of the disclosed mitigation.
Under the terms disclosed in this document, GPT-5.5 is subject to usage policy restrictions on biological and chemical weapons-relevant content, with policy enforcement serving as the primary control mechanism. Access to this category of content is not described as subject to an absolute technical block.
Cross-platform context
See how other platforms handle Biological and Chemical Risk Assessment and similar clauses.
Compare across platforms →Monitoring
OpenAI has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 25 platforms.
"GPT-5.5 was evaluated for potential uplift in biological and chemical threat domains as part of the Preparedness Framework assessment. The model received a medium risk rating in these categories, with mitigations including usage policy restrictions on content related to weapons of mass destruction.— Excerpt from OpenAI's OpenAI GPT-5.5 System Card
1) REGULATORY LANDSCAPE: Biological and chemical threat uplift capabilities engage the Biological Weapons Anti-Terrorism Act and the Chemical Weapons Convention Implementation Act in the US, as well as equivalent biosecurity and chemical security frameworks in other jurisdictions. Export control regulations administered by the US Department of Commerce and State Department may apply to the export of AI systems with assessed dual-use capabilities in these domains. The EU AI Act's systemic risk provisions are also relevant. 2) GOVERNANCE EXPOSURE: High. The disclosure of medium-rated biological and chemical threat uplift capability, managed primarily through usage policy enforcement, creates significant governance exposure for regulators and enterprise operators in biosecurity-sensitive contexts. The adequacy of policy-based mitigations for this category of risk is subject to ongoing regulatory scrutiny. 3) JURISDICTION FLAGS: US federal law enforcement and intelligence agencies maintain oversight interests in AI systems with assessed bioweapons-adjacent capabilities. EU biosecurity and dual-use export control authorities are relevant for European deployments. Any cross-border provision of API access to this model may require export control analysis. 4) CONTRACT AND VENDOR IMPLICATIONS: Operators providing GPT-5.5 access in research, life sciences, or defense-adjacent contexts should conduct specific due diligence on their obligations under applicable biosecurity and export control frameworks and should not rely solely on OpenAI's usage policy enforcement as their compliance mechanism. 5) COMPLIANCE CONSIDERATIONS: Life sciences and defense sector operators should conduct specific risk assessments for GPT-5.5 deployments referencing this disclosure and should implement supplementary technical and procedural controls beyond what OpenAI's usage policies provide. Legal teams should evaluate whether applicable biosecurity regulations impose affirmative obligations to restrict AI system access in ways that go beyond usage policy enforcement.
Full compliance analysis
Regulatory citations, enforcement risk, and due diligence action items.
Free: track 3 platforms + weekly digest. Monitor: 25 platforms + same-day alerts. No credit card required.
Compliance Governance Intelligence
Need to monitor specific governance provisions?
Compliance includes provision-level monitoring, governance timelines, regulatory mapping, and audit-ready analysis.
Built from archived source documents, structured governance mappings, and historical version tracking.
The disclosure that GPT-5.5 was evaluated and rated at medium risk in biological and chemical threat domains is operationally significant for regulatory compliance purposes, as these domains are subject to specific legal restrictions in most jurisdictions. The primary mitigation described is usage policy enforcement rather than absolute technical restriction.
Under the terms disclosed in this document, GPT-5.5 is subject to usage policy restrictions on biological and chemical weapons-relevant content, with policy enforcement serving as the primary control mechanism. Access to this category of content is not described as subject to an absolute technical block.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by OpenAI.